Scandion Oncology A/S (SCOL) — Net Asset Momentum
Scandion Oncology A/S (SCOL) recorded a net asset momentum of -73.4% as of December 2024, with net assets of Skr8.27 Million SEK. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check Scandion Oncology A/S (SCOL) tangible net worth to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
Scandion Oncology A/S Net Asset Momentum (2017–2024)
This chart tracks Scandion Oncology A/S's year-over-year net asset growth across 8 annual reporting periods from 2017 to 2024. The most recent momentum reading is -73.4%, with net assets of Skr8.27 Million SEK as of December 2024. Read SCOL total debt and obligations for a breakdown of total debt and financial obligations.
Annual Net Asset History for Scandion Oncology A/S (2017–2024)
The table below shows the complete annual net asset history for Scandion Oncology A/S from 2017 to 2024, covering 8 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see how much is Scandion Oncology A/S worth.
| Year | Net Assets (SEK) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | Skr8.27 Million | Skr18.28 Million | Skr10.01 Million | ▼ -73.4% |
| 2023 | Skr31.12 Million | Skr34.56 Million | Skr3.44 Million | ▼ -55.7% |
| 2022 | Skr70.33 Million | Skr89.40 Million | Skr19.07 Million | ▼ -32.7% |
| 2021 | Skr104.54 Million | Skr116.22 Million | Skr11.68 Million | ▼ -32.9% |
| 2020 | Skr155.87 Million | Skr186.41 Million | Skr30.54 Million | ▲ +749.9% |
| 2019 | Skr18.34 Million | Skr19.90 Million | Skr1.56 Million | ▲ +45.9% |
| 2018 | Skr12.57 Million | Skr13.56 Million | Skr992.64K | ▲ +765.3% |
| 2017 | Skr1.45 Million | Skr1.96 Million | Skr509.02K | — |